Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease

NCT03327857 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Steroid-refractory Acute Graft-versus-Host Disease
Treatment-refractory Acute Graft-versus-Host Disease

Interventions

BIOLOGICAL: Neihulizumab (ALTB-168)

Sponsor

AltruBio Inc.